Related Experiment Video
Updated: Aug 29, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Analysis of Mortality in Unvaccinated Patients with COVID-19 and Cardiovascular Risk
Kathie Sarzyńska1, Filip Świątkowski2,3, Jarosław Janc4
1Department of Nursing and Obstetrics, Faculty of Health Science, Wroclaw Medical University, 5 Bartla Street, 51-618 Wroclaw, Poland.
Insights
Predicting COVID-19 in-hospital death is crucial. Key laboratory markers like troponin, creatinine, D-dimers, and C-reactive protein levels can identify unvaccinated patients with cardiovascular disease at higher risk.
Area of Science:
- Internal Medicine
- Cardiology
- Infectious Diseases
Background:
- COVID-19 poses a significant global health threat, causing millions of fatalities worldwide.
- Identifying high-risk patients early is essential for targeted interventions to reduce in-hospital mortality.
- Cardiovascular disease is a common comorbidity in severe COVID-19 cases.
Purpose of the Study:
- To identify baseline laboratory parameters that predict in-hospital death in unvaccinated COVID-19 patients with cardiovascular disease.
- To establish cut-off values for specific blood tests indicative of increased mortality risk.
Main Methods:
- Retrospective analysis of 446 unvaccinated COVID-19 patients with cardiovascular disease from an initial cohort of 1234.
- Multivariate regression analysis was employed to determine independent predictors of in-hospital death.
Main Results:
- Elevated troponin (≥ 0.033 μg/L), creatinine (≥ 1.88 mg/dL), D-dimers (≥ 0.97 g/L), and C-reactive protein (≥ 0.89 mg/L) were identified as independent predictors of death.
- Odds ratios for these predictors ranged from 2.04 to 2.88, indicating significantly increased mortality risk.
Conclusions:
- Specific laboratory values can serve as crucial indicators for in-hospital mortality risk in unvaccinated COVID-19 patients with cardiovascular disease.
- These findings support the use of routine blood tests to stratify risk and guide clinical management for improved patient outcomes.
Abstract:
COVID-19 is a contagious disease that has spread globally, killing millions of people around the world. In order to reduce the likelihood of in-hospital death due to COVID-19, it is reasonable to select a group of patients with a low probability of survival and to implement measures in advance to minimize the risk of death. One way to do this is to establish cut-off values for the most commonly performed blood laboratory tests, above or below which the likelihood of death increases significantly. The aim of the study was to determine the basic laboratory parameters among unvaccinated patients hospitalized for COVID-19 with concomitant cardiovascular disease, which are the predictors of in-hospital death. Out of 1234 patients, 446 people who met the specific inclusion criteria were enrolled in the study. The multivariate regression analysis has shown that the independent predictors of death are: troponin levels of at least 0.033 μg/L (OR = 2.04 [1.10; 3.79]), creatinine of at least 1.88 mg/dL (OR = 2.88 [1.57; 5.30]), D-dimers of at least 0.97 g/L (OR = 2.04 [1.02; 4.07]), and C-reactive protein minimum of 0.89 mg/L (OR = 2.28 [1.24; 4.18]).
More Related Videos
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Myocarditis III: Medical Management
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Bias in Epidemiological Studies
Coronary Artery Disease IV: Preventive Measures